AGI-5198 is a potent and selective inhibitor of IDH1 R132H and R132C mutants with IC50 values of 0.07 and 0.16 µM, respectively, but not wild-type IDH1, wild-type IDH2, or IDH2 mutants.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | Isocitrate dehydrogenases (IDHs) catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. IDH1 is a NADP(+)-dependent isocitrate dehydrogenase found in the cytoplasm and peroxisomes. IDH1 plays a significant role in cytoplasmic NADPH production. Somatic mutations in IDH1 have recently been identified in multiple human cancers. Mutation at the site of R132 of IDH1 confers on this enzyme a new activity: catalysis of alpha-ketoglutarate (2-OG) to the (R)-enantiomer of 2-hydroxyglutarate (R-2HG). AGI-5198 is a selective inhibitor of R132H or R132C mutated IDH1. The inhibitory IC50s of AGI-5198 against R132H-IDH1 and R132C-IDH1 are 70 nM and 160 nM, respectively. AGI-5198 impaired soft-agar colony formation of glioma TS603 cells bearing R132H-IDH1 at the concentrations of 375 nM and 3000 nM. AGI-5198 suppressed 2-HG production in HT1080 and U87MG cells with IC50 values of 0.48 μM and 0.07 μM, respectively[3]. In R132H-IDH1 bearing TS603 glioma xenografts established in SCID mice, AGI-5198 administrated orally at the dose of 450 mg/kg daily for 3 weeks caused 50-60% tumor growth inhibition, while this same dosing had no affect on the growth of IDH1 wild-type TS516 xenografts[3]. |
作用机制 | AGI-5198 inhibits the IDH1-R132H mutant homodimer. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
human HT1080 cells | Function assay | 48 h | Inhibition of IDH1 R132C mutant overexpressed in human HT1080 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis, IC50=0.48 μM | 24900389 | |
human U87 cells | Function assay | 48 h | Inhibition of IDH1 R132H mutant expressed in human U87 cells assessed as inhibition of 2-hydroxyglutarate production after 48 hrs by LC/MS analysis, IC50=0.07 μM | 24900389 |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.16mL 0.43mL 0.22mL |
10.81mL 2.16mL 1.08mL |
21.62mL 4.32mL 2.16mL |
CAS号 | 1355326-35-0 |
分子式 | C27H31FN4O2 |
分子量 | 462.559 |
别名 | IDH-C35 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 20 mg/mL(43.24 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO DMF: 50 mg/mL(108.09 mM) |
动物实验配方 |
0.5% methylcellulose+0.2% Tween 80+water 30 mg/mL suspension |